1107 related articles for article (PubMed ID: 15731895)
21. Metabotropic glutamate receptors for new treatments in schizophrenia.
Herman EJ; Bubser M; Conn PJ; Jones CK
Handb Exp Pharmacol; 2012; (213):297-365. PubMed ID: 23027420
[TBL] [Abstract][Full Text] [Related]
22. Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
Johansen TN; Greenwood JR; Frydenvang K; Madsen U; Krogsgaard-Larsen P
Chirality; 2003 Feb; 15(2):167-79. PubMed ID: 12520509
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders.
Gregory KJ; Noetzel MJ; Niswender CM
Prog Mol Biol Transl Sci; 2013; 115():61-121. PubMed ID: 23415092
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and pharmacology of 3-hydroxy-delta2-isoxazoline-cyclopentane analogues of glutamic acid.
Conti P; De Amici M; Bräuner-Osborne H; Madsen U; Toma L; De Micheli C
Farmaco; 2002 Nov; 57(11):889-95. PubMed ID: 12484537
[TBL] [Abstract][Full Text] [Related]
25. Cyclothiazide selectively inhibits mGluR1 receptors interacting with a common allosteric site for non-competitive antagonists.
Surin A; Pshenichkin S; Grajkowska E; Surina E; Wroblewski JT
Neuropharmacology; 2007 Mar; 52(3):744-54. PubMed ID: 17095021
[TBL] [Abstract][Full Text] [Related]
26. Partial agonists and subunit selectivity at NMDA receptors.
Risgaard R; Hansen KB; Clausen RP
Chemistry; 2010 Dec; 16(47):13910-8. PubMed ID: 20945316
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
[TBL] [Abstract][Full Text] [Related]
28. Glutamate- and GABA-based CNS therapeutics.
Foster AC; Kemp JA
Curr Opin Pharmacol; 2006 Feb; 6(1):7-17. PubMed ID: 16377242
[TBL] [Abstract][Full Text] [Related]
29. New therapeutic frontiers for metabotropic glutamate receptors.
Niswender CM; Jones CK; Conn PJ
Curr Top Med Chem; 2005; 5(9):847-57. PubMed ID: 16178730
[TBL] [Abstract][Full Text] [Related]
30. Regulation of MAPK/ERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons.
Mao L; Tang Q; Samdani S; Liu Z; Wang JQ
Eur J Neurosci; 2004 Mar; 19(5):1207-16. PubMed ID: 15016079
[TBL] [Abstract][Full Text] [Related]
31. Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors.
Bráuner-Osborne H; Nielsen B; Stensbøl TB; Johansen TN; Skjaerbaek N; Krogsgaard-Larsen P
Eur J Pharmacol; 1997 Sep; 335(2-3):R1-3. PubMed ID: 9369383
[TBL] [Abstract][Full Text] [Related]
32. The glutamatergic system as a target for neuropathic pain relief.
Osikowicz M; Mika J; Przewlocka B
Exp Physiol; 2013 Feb; 98(2):372-84. PubMed ID: 23002244
[TBL] [Abstract][Full Text] [Related]
33. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
[TBL] [Abstract][Full Text] [Related]
34. Activation of AMPA and kainate glutamate receptors impairs the viability of oligodendrocytes in vitro.
Sanchez-Gomez MV; Matute C
Int J Dev Biol; 1996; Suppl 1():187S-188S. PubMed ID: 9087754
[No Abstract] [Full Text] [Related]
35. mGluR5 antagonists: discovery, characterization and drug development.
Gasparini F; Bilbe G; Gomez-Mancilla B; Spooren W
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):655-65. PubMed ID: 18729017
[TBL] [Abstract][Full Text] [Related]
36. Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.
Rodriguez AL; Grier MD; Jones CK; Herman EJ; Kane AS; Smith RL; Williams R; Zhou Y; Marlo JE; Days EL; Blatt TN; Jadhav S; Menon UN; Vinson PN; Rook JM; Stauffer SR; Niswender CM; Lindsley CW; Weaver CD; Conn PJ
Mol Pharmacol; 2010 Dec; 78(6):1105-23. PubMed ID: 20923853
[TBL] [Abstract][Full Text] [Related]
37. [Glutamate lonotropic Receptors: Structure, Localisation, Function].
Perfilova VN; Tyurenkov IN
Usp Fiziol Nauk; 2016; 47(1):80-96. PubMed ID: 27149825
[TBL] [Abstract][Full Text] [Related]
38. Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats.
O'neill MF; Sanger G; Ornstein PL; Osborne DJ; Woodhouse SM
Psychopharmacology (Berl); 2005 Apr; 179(1):181-8. PubMed ID: 15821949
[TBL] [Abstract][Full Text] [Related]
39. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
40. Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes.
Frati C; Marchese C; Fisichella G; Copani A; Nasca MR; Storto M; Nicoletti F
J Cell Physiol; 2000 Jun; 183(3):364-72. PubMed ID: 10797311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
